Autologous stem cell transplantation after conditioning with yttrium-90 ibritumomab tiuxetan BEAM in refractory non-Hodgkin diffuse large B-cell lymphoma: results of a prospective, multicenter, phase II clinical trial

Haematologica. 2014 Jul;99(7):e126. doi: 10.3324/haematol.2014.108308.
No abstract available

Keywords: autologous transplantation; diffuse large B-cell lymphoma; ibritumomab tiuxetan; relapse.

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma, Large B-Cell, Diffuse / therapy*
  • Male
  • Transplantation Conditioning*